Progenics, Regeneron announce positive product news

By Leif Skodnick

No Comment

Regeneron announces positive study results for a sinus drug, and Progenics’ drug Relistor gains another approved use by the U.S. Food and Drug Administration.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author

Leif Skodnick
Leif Skodnick is a former reporter for Westfair Communications. He is a graduate of Columbia Journalism School, Mississippi College School of Law, and St. Lawrence University.

Related Articles